China Pharma Holdings Inc Capital Reinvestment Ratio

Latest as of June 2025: 0.03x

China Pharma Holdings Inc capital reinvestment ratio. China Pharma Holdings Inc (CPHI) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow ($291.08K) in capital expenditures ($9.92K). Check how aggressively does China Pharma Holdings Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

$291.08K
USD

Capital Expenditures

$9.92K
USD

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of China Pharma Holdings Inc (2007–2019)

Capital reinvestment ratio of China Pharma Holdings Inc from 2007 to 2019. This chart tracks China Pharma Holdings Inc's Capital Reinvestment Ratio across 13 annual periods. Also explore China Pharma Holdings Inc net asset momentum to track the company's year-over-year net asset growth rate.

China Pharma Holdings Inc Capital Reinvestment Ratio by Year (2007–2019)

China Pharma Holdings Inc capital reinvestment ratio by year from 2007 to 2019. For the full cash flow conversion analysis, see CPHI operating cash flow.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.22x $608.31K $136.00K ▲ +449.5%
2018 0.04x $1.26 Million $51.15K ▼ -74.9%
2017 0.16x $841.22K $136.48K ▲ +142.9%
2016 0.07x $2.90 Million $193.40K ▼ -90.4%
2015 0.69x $3.35 Million $2.32 Million ▼ -45.8%
2014 1.28x $4.57 Million $5.84 Million ▼ -42.5%
2013 2.22x $8.60 Million $19.09 Million ▲ +62.3%
2012 1.37x $3.64 Million $4.99 Million ▲ +29.3%
2011 1.06x $5.24 Million $5.54 Million ▼ -21.7%
2010 1.35x $7.79 Million $10.52 Million ▼ -6.2%
2009 1.44x $10.67 Million $15.36 Million ▲ +10.9%
2008 1.30x $6.54 Million $8.49 Million ▲ +21.7%
2007 1.07x $2.80 Million $2.99 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow